Breaking News: Pomerantz Law Firm Launches Investigation into Amylyx Pharmaceuticals Inc. for Shareholder Claims
Investigation into Amylyx Pharmaceuticals, Inc. for Securities Fraud New York, Dec. 18, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Amylyx Pharmaceuticals, Inc. (“Amylyx” or the “Company”) (NASDAQ: AMLX). Investigation Details Investors of Amylyx Pharmaceuticals, Inc. are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation…